Literature DB >> 4412078

Arginine-rich low molecular peptides in human neoplastic serum.

R Farbiszewski, W Rzeczycki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4412078     DOI： 10.1007/BF01938322

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  6 in total

1.  Peptides in human urine.

Authors:  B SKARZYNSKI; M SARNECKA-KELLER
Journal:  Adv Clin Chem       Date:  1962       Impact factor: 5.394

2.  Peptides isolated from the serum of cases of leukemia.

Authors:  G HAMMARSTEN; B M SANDELL
Journal:  Scand J Clin Lab Invest       Date:  1958       Impact factor: 1.713

3.  The arginine content in fibrin clots and fibrinolysis in neoplastic diseases.

Authors:  R Farbiszewski; W Rzeczycki; K Worowski; S Glowinski
Journal:  Neoplasma       Date:  1973       Impact factor: 2.575

4.  The specificity of an increase of albumin fraction arginine in neoplastic diseases.

Authors:  R Farbiszewski; K Worowski; W Rzeczycki
Journal:  Bull Acad Pol Sci Biol       Date:  1971

5.  Arginine content in serum protein and in serum protein fractions in cases of neoplastic disease.

Authors:  R Farbiszewski; K Worowski; W Rzeczycki
Journal:  Neoplasma       Date:  1971       Impact factor: 2.575

6.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12
  6 in total
  2 in total

1.  Cytoplasmic 14C-labeled arginine basic proteins of Ehrlich ascites tumour cells.

Authors:  R Farbiszewski; D Kilczewska; W Rzeczycki
Journal:  Experientia       Date:  1980-05-15

2.  A unified resource and configurable model of the synapse proteome and its role in disease.

Authors:  Oksana Sorokina; Colin Mclean; Mike D R Croning; Katharina F Heil; Emilia Wysocka; Xin He; David Sterratt; Seth G N Grant; T Ian Simpson; J Douglas Armstrong
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.